News
Longtime ESPN "Sports Center" anchor Jay Harris has been diagnosed with prostate cancer and is scheduled to have surgery ...
StockStory.org on MSN1h
DraftKings, Teladoc, Rush Street Interactive, Moderna, and Avis Budget Group Shares Are Soaring, What You Need To KnowWhat Happened? A number of stocks jumped in the afternoon session after the major indices rebounded, as the Bureau of Labor ...
The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...
A new injection to prevent HIV is expected to be approved by the U.S. Food and Drug Administration later this month.
The S&P 500 added 1% on Friday, June 6, as a strong jobs report pointed to resilience in the labor market despite ...
The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...
CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...
We have never seen anything close to as good as what we are seeing, in terms of how well we are able to reveal this virus.' ...
Writing for SBM these days is a bit like being in one of those cash grab machines, though instead of money flying over the place, it’s bees and wasps. Every week brings a fresh round of horrors that ...
The new center at the University of Utah focuses on helping stroke patients live a productive life after a stroke.
6h
Zacks Investment Research on MSNWhy Is Mirum Pharmaceuticals (MIRM) Down 1.3% Since Last Earnings Report?It has been about a month since the last earnings report for Mirum Pharmaceuticals, Inc. (MIRM). Shares have lost about 1.3% in that time frame, underperforming the S&P 500. Will the recent negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results